Classified in categories
Aphtae and pressure sores in the oral cavity * Children, newborns: complete care * Medicaments for children * OTC, Prescription drugs * Sore throat and laryngitis * Throat and the oral cavityOROFAR lozenges 24
| Application form | tablets, capsules |
| Indication group | otorhinolaryngologicals |
| Manufacturer | Novartis s.r.o., Prague, Czech Republic, www.novartis.com |
| Active substance | Benzoxonii chloridum 1 mg, Lidocaini hydrochloridum monohydricum 1 mg |
| minimum amount for dispatch | Orofar contains a substance effective against infection and a substance which causes desensitisation (anaesthetic). It is used for the treatment of inflammations of the oral cavity and the pharynx. Orofar is available in form of lozenges, spray and solution for rinsing or gargling. |
Summary of product characteristics  SHOW | Information on a drug is available on the official website: Medicines.org.uk or EMEA : European Medicines Agency |
| SUKL | OROFAR orm pas 24 - 0016433 |
